Yi Y, et al
Wegovy (Injectable) Wegovy (semaglutide) injectable, a FDA-approved GLP-1 receptor agonist, taken once a week with an auto-injector pen, to help regulate appetite and feelings of fullness
Handbook of clinical neurology
Patients were excluded if they had any other chronic liver disease other than MASLD/MASH including alcohol, viral, drug-induced, autoimmune, Budd-Chiari syndrome, Wilsons disease, alpha-1-antitrypsin deficiency, hereditary hemochromatosis, primary/secondary biliary cholangitis, primary sclerosing cholangitis, liver disorders in diseases classified elsewhere, and other chronic hepatitis not classified elsewhere
RG participated in the design, coordination of the study and finalized the manuscript